HEALTH

‘Pharmacist Sentiment Report’ gets inside the heads of today’s busiest pharmacists

BY DSN STAFF

NEW YORK — What new prescription and OTC drugs are top of mind among retail pharmacists? How often do pharmacists REALLY recommend private label? Market Research Solutions asked those questions and more to a panel of more than 200 retail pharmacists from leading chains for its "2011 Pharmacist Sentiment Report" (click here).

Compiled from phone interviews with practicing pharmacists from chains such as Walgreens, CVS, Rite Aid, Target and Walmart, the 32-page report is loaded with exclusive charts and data that provide a clear and concise picture of what today’s pharmacists think about current topics and trends, including —

• new Rx and OTC drugs that are front of mind.
• recent private label recommendation activity.
• most common patient questions.
• recent product inventory issues.
• obstacles and opportunities to better serve patients.
• what they’re doing to improve patient adherence and clinical outcomes, and more.

Responses are measured both in survey totals, as well as broken out by chain. To download a copy of the report, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Study: Quitting smoking could breathe new happiness into life

BY Michael Johnsen

NEW YORK — Compared with those who continue to smoke, quitters are both happier and more satisfied with their health, both one year and three years afterward, than those who continue to smoke, according to new research published last week in the journal Annals of Behavioral Medicine.

Smokers hold strong beliefs about how stopping smoking will reduce their quality of life. Positive experiences of smoking cessation, including improved well-being, could be used by clinicians to educate and motivate individuals to stop smoking.

The authors assessed overall quality of life, health-related quality of life, positive versus negative emotions, relationship satisfaction and occurrence of stressors among 1,504 smokers taking part in a smoking-cessation trial in the United States. Smoking status and quality of life were assessed at both one year and three years post-smoking cessation.

Quality of life measures included health, self-regard, philosophy of life, standard of living, work, recreation, learning, creativity, social service, love relationship, friendships, relationships with children, relationships with relatives, home, neighborhood and community.

"This research provides substantial evidence that quitting smoking benefits well-being compared [with] continuing smoking," stated lead researcher Megan Piper of the University of Wisconsin School of Medicine and Public Health. "Smokers might believe that quitting will decrease life satisfaction or quality of life because they believe it disrupts routines, interferes with relationships, leads to a loss of smoking-related pleasure or because cessation deprives them of a coping strategy. Our findings suggest that over the long-term, individuals will be happier and more satisfied with their lives if they stop smoking than if they do not."

 


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Goldstein Group unveils brand rejuvination for Bayer’s Neo-Synephrine

BY Michael Johnsen

MORRISTOWN, N.J. — Bayer recently engaged the Goldstein Group to rejuvenate the cough-cold Neo-Synephrine brand and improve the brand’s identity on shelf.

The brand design group employs such tools as its trademarked Shelf Sight Sequence, a packaging design service that improves shelf presence with "a visual vocabulary of proprietary colors, shapes, symbols and verbiage … to trigger the consumer’s purchasing impulse at first sight."

"TGG evolved [NeoSynephrine’s] on-shelf presence by increasing the ‘fast acting’ and ‘focused relief’ [that] NeoSynephrine provides by incorporating a stylized telescopic sight and spotlight effect into the brand’s logotype," noted Terri Goldstein, TGG CEO. "TGG also refreshed and realigned packaging elements to improve the impact of the product’s efficacy, benefits and range of offerings. Now, the brand has a revitalized shelf-strategy that may be quickly felt and understood."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?